The present experiments interrogated the role of JAKs regulating Myc expression using the JAK inhibitor tofacitinib: a drug showing clinical promise for the treatment of autoimmune diseases (Hsu & Armstrong, 2014; Lee et al, 2014). The gene discussed is MYC; the disease is autoimmune disease.